| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |